Breaking News Headlines Today | Ground News

See every side of every news story

Interventional News image

News from Interventional News

The Ground News media bias check for Interventional News is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and AllSides.

Interventional News’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Interventional News

Where is Interventional News located?Interventional News's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Interventional News News

Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System

Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System

Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular tumor embolization supported by a prospective, randomized, controlled clinical trial See the Story

SonoMotion Gains FDA Clearance for Break Wave Device to Treat Kidney Stones

United States · United States

SonoMotion Gains FDA Clearance for Break Wave Device to Treat Kidney Stones

SonoMotion has received the US Food and Drug Administration (FDA) 510(k) clearance for its Break Wave non-invasive kidney stone treatment device.The post SonoMotion gains FDA clearance for Break Wave device to treat kidney stones appeared first on Medical Device Network.See the Story

Positive NOVARAD study results could herald “new era” for radiation protection

Besançon · Besançon

Positive NOVARAD study results could herald “new era” for radiation protection

Nova-X Cathpax—a spinoff of the Lemer Pax group that designs, develops and commercialises team-wide, full-body radiation protection systems for interventional medicine practitioners—has today announced positive results from the NOVARAD clinical study. This study is described by the company as the “first ever” to evaluate exposure to X-rays in interventional neuroradiology, with the aim of assessing the effectiveness of Nova-X in protecting the e…See the Story

Breaking News Topics Related to Interventional News